Unlock instant, AI-driven research and patent intelligence for your innovation.

Substituted 6,5-fused bicyclic heteroaryl compounds

a technology of bicyclic heteroaryl compounds and substituted compounds, which is applied in the direction of organic chemistry, organic active ingredients, drug compositions, etc., can solve the problems of complexes lacked the ability to catalyze the methylation of the equivalent residue of h3-k27 of a peptidic substrate, disrupted control, and disease states, etc., to inhibit the conversion of h3-k27 and inhibit the activity of histone methyltransfer

Active Publication Date: 2013-11-28
EPIZYME
View PDF0 Cites 8 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

The present invention features a new compound, called a substituted 6,5-fused bicyclic heteroaryl compound, and its pharmaceutically acceptable salts or esters. This compound has various uses in medicine and can be easily prepared using specific chemical methods. The technical effect of this invention is the provision of a new compound that can be used for the treatment of various diseases and disorders.

Problems solved by technology

Disease states result when these controls are disrupted by aberrant expression and / or activity of the enzymes responsible for DNA and histone modification.
It was also demonstrated that all of the mutant forms of EZH2 could be incorporated into the multi-protein PRC2 complex, but that the resulting complexes lacked the ability to catalyze methylation of the H3-K27 equivalent residue of a peptidic substrate.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Substituted 6,5-fused bicyclic heteroaryl compounds
  • Substituted 6,5-fused bicyclic heteroaryl compounds
  • Substituted 6,5-fused bicyclic heteroaryl compounds

Examples

Experimental program
Comparison scheme
Effect test

example 1

[0801]The compounds listed in Tables 1-6 were synthesized by reaction schemes depicted in the general schemes above or by methods described below.

Synthesis of Compound A-1: 1-cyclopentyl-N-((4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-6-(4-(morpholinomethyl)phenyl)-1H-pyrazolo[3,4-b]pyridine-4-carboxamide

[0802]

Step 1: Synthesis of 3-(aminomethyl)-4,6-dimethylpyridin-2(1H)-one

[0803]

[0804]3-Cyano-2,4-dimethyl-2-hydroxypyridine (0.3 g, 2.0 mmol) was dissolved in MeOH (5 mL), to which catalytic amount of Raney Ni and of aqueous NH3 (0.3 mL) were added and the reaction mixture was stirred under hydrogen pressure (bladder pressure) for 3-4 h. After completion of the reaction, catalyst was filtered off and the filtrate was concentrated under reduced pressure. The residue was thoroughly dried to provide the desired product (0.3 g, quantitative yield).

Step 2: Synthesis of ethyl 6-hydroxy-1H-pyrazolo[3,4-b]pyridine-4-carboxylate

[0805]

[0806]A stirred solution of 1H-pyrazol-3-amine (45 g...

example 2

Bioassay Protocol and General Methods

Protocol for Wild-Type and Mutant PRC2 Enzyme Assays

[1382]General Materials.

[1383]S-adenosylmethionine (SAM), S-adenosylhomocyteine (SAH), bicine, KCl, Tween20, dimethylsulfoxide (DMSO) and bovine skin gelatin (BSG) were purchased from Sigma-Aldrich at the highest level of purity possible. Dithiothreitol (DTT) was purchased from EMD. 3H-SAM was purchased from American Radiolabeled Chemicals with a specific activity of 80 Ci / mmol 384-well streptavidin Flashplates were purchased from PerkinElmer.

[1384]Substrates.

[1385]Peptides representative of human histone H3 residues 21-44 containing either an unmodified lysine 27 (H3K27me0) or dimethylated lysine 27 (H3K27me2) were synthesized with a C-terminal G(K-biotin) linker-affinity tag motif and a C-terminal amide cap by 21st Century Biochemicals. The peptides were high-performance liquid chromatography (HPLC) purified to greater than 95% purity and confirmed by liquid chromatography mass spectrometry (L...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
Pharmaceutically acceptableaaaaaaaaaa
Login to View More

Abstract

The present invention relates to substituted 6,5-fused bicyclic heteroaryl compounds. The present invention also relates to pharmaceutical compositions containing these compounds and methods of treating cancer by administering these compounds and pharmaceutical compositions to subjects in need thereof.

Description

RELATED APPLICATIONS[0001]This application is a continuation of International Application PCT / US2012 / 026953, with an international filing date of Feb. 28, 2012, which claims priority to, and the benefit of, U.S. provisional application Nos. 61 / 447,632, filed Feb. 28, 2011, 61 / 447,625, filed Feb. 28, 2011, 61 / 447,626 filed Feb. 28, 2011, 61 / 447,627 filed Feb. 28, 2011, and 61 / 447,629 filed Feb. 28, 2011, the entire contents of each of which are incorporated herein by reference in their entireties.INCORPORATION-BY-REFERENCE OF SEQUENCE LISTING[0002]The contents of the text file named “41478503001WOST25.txt”, which was created on Feb. 28, 2012 and is 2 KB in size, are hereby incorporated by reference in their entireties.BACKGROUND OF THE INVENTION[0003]In eukaryotic cells DNA is packaged with histones to form chromatin. Changes in the ordered structure of chromatin can lead to alterations in transcription of associated genes. Control of changes in chromatin structure (and hence of tran...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C07D401/12
CPCC07D401/12C07D401/04C07D401/14C07D405/14C07D413/14A61P35/00C07D471/04
Inventor KUNTZ, KEVIN WAYNEOLHAVA, EDWARD JAMESCHESWORTH, RICHARDDUNCAN, KENNETH WILLIAM
Owner EPIZYME